Belvedere Trading LLC Galera Therapeutics, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$2.5 - $3.42 $53,285 - $72,893
21,314 New
21,314 $66,000
Q2 2022

Jul 21, 2022
SELL
$1.24 - $2.39 $125,752 - $242,377
-101,413 Closed
0 $0
Q1 2022

Apr 20, 2022
BUY
$2.01 - $4.19 $9,903 - $20,644
4,927 Added 5.11%
101,413 $207,000
Q4 2021

Jan 25, 2022
BUY
$1.27 - $8.28 $122,537 - $798,904
96,486 New
96,486 $255,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email